give me top 5 research papers related to hypertension
Reading Document
Medical Text Search
hypertension research landmark studies clinical trials
Medical Text Search
hypertension blood pressure treatment guidelines evidence
GradeResponse
GradeResponse
Here are 5 landmark research papers related to hypertension that have significantly shaped clinical practice:
1. SPRINT Trial (2015)
Systolic Blood Pressure Intervention Trial
- Published in: New England Journal of Medicine (2015)
- Key Finding: Targeting a systolic BP <120 mmHg (intensive control) reduced major cardiovascular events by ~25% and all-cause mortality by ~27% compared to the standard target of <140 mmHg.
- Impact: Directly influenced the 2024 ESH/ESC Guidelines recommendation to pursue a systolic BP target of 120–129 mmHg in treated adults (Management of Elevated Blood Pressure and Hypertension, p. 8).
2. Veterans Administration Cooperative Study on Antihypertensive Agents (1967–1970)
- Published in: JAMA
- Key Finding: One of the earliest landmark RCTs demonstrating that treating hypertension to a diastolic BP <90 mmHg substantially reduced strokes, heart failure, and other cardiovascular events vs. placebo.
- Impact: Established the foundational evidence base for antihypertensive treatment, cited by VA/DoD HTN CPG (Diagnosis and Management of Hypertension in Primary Care, p. 38).
3. ALLHAT Trial (2002)
Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial
- Published in: JAMA
- Key Finding: Thiazide diuretics (chlorthalidone) were at least as effective as ACE inhibitors (lisinopril) and calcium channel blockers (amlodipine) in preventing cardiovascular outcomes and were superior in preventing heart failure.
- Impact: Reinforced thiazide diuretics as a first-line therapy in hypertension management.
4. Hypertension Detection and Follow-up Program (HDFP, 1979)
- Published in: JAMA
- Key Finding: Systematic, stepped-care antihypertensive treatment reduced 5-year all-cause mortality by 17% compared to referred-care in patients with diastolic BP ≥90 mmHg.
- Impact: Confirmed broad population-level benefit of treating even mild hypertension; cited in VA/DoD HTN CPG (Diagnosis and Management of Hypertension in Primary Care, p. 38).
5. 2024 ESH Guidelines — Evidence Review (2024)
"Management of Elevated Blood Pressure and Hypertension"
- Published in: European Heart Journal
- Key Finding: Introduced the new "Elevated BP" category (systolic 120–139 mmHg), shifted the treatment target to systolic 120–129 mmHg for medicated patients, and extended evidence for BP-lowering benefits even below the traditional hypertension threshold in high-CVD-risk individuals (Management of Elevated Blood Pressure and Hypertension, p. 8).
- Impact: Represents the most current evidence-based framework for hypertension classification and management globally.
| # | Study | Year | Key Takeaway |
|---|---|---|---|
| 1 | SPRINT | 2015 | Intensive BP control (<120 mmHg) reduces CV events & mortality |
| 2 | VA Cooperative Study | 1967–70 | First RCT proving antihypertensives reduce CV events |
| 3 | ALLHAT | 2002 | Thiazide diuretics are optimal first-line agents |
| 4 | HDFP | 1979 | Systematic treatment reduces all-cause mortality by 17% |
| 5 | 2024 ESH Guidelines | 2024 | New "Elevated BP" category; target SBP 120–129 mmHg |
These five studies collectively trace the evolution of hypertension management from proof-of-concept (VA/HDFP) to refined treatment targets (SPRINT, 2024 ESH), and drug selection (ALLHAT).
hello
Hello! How can I help you today?
This is a shared conversation. Sign in to Orris to start your own chat.